Mutations of the EPHB6 Receptor Tyrosine Kinase Induce a Pro-Metastatic Phenotype in Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Mutations of the EPHB6 Receptor Tyrosine Kinase Induce a Pro-Metastatic Phenotype in Non-Small Cell Lung Cancer

Published:2012-12-04 Issue:12 Volume:7 Page:e44591
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bulk Etmar,Yu Jun,Hascher Antje,Koschmieder Steffen,Wiewrodt Rainer,Krug Utz,Timmermann Bernd,Marra Alessandro,Hillejan Ludger,Wiebe Karsten,Berdel Wolfgang E.,Schwab Albrecht,Müller-Tidow Carsten

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference29 articles.

1. Cancer Statistics;A Jemal;Ca Cancer J clin,2010

2. Prognostic factors in NSCLC. Recent experiences;N van Zandwijk;Lung Cancer,1995

3. Role of tyrosine kinase inhibitors in lung cancer;J Ansari;Anticancer Agents Med Chem,2009

4. Gene expression profiling and non-small-cell lung cancer: where are we now?;ES Santos;Clin Lung Cancer,2009

5. EGFR-targeted therapies in lung cancer: predictors of response and toxicity;RS Heist;Pharmacogenomics,2009

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erythropoietin-producing hepatocellular receptor B6 is highly expressed in non-functioning pituitary neuroendocrine tumors and its expression correlates with tumor size;Molecular Biology Reports;2024-02-11

2. Eph receptors and ephrins in cancer progression;Nature Reviews Cancer;2023-11-23

3. May EPH/Ephrin Targeting Revolutionize Lung Cancer Treatment?;International Journal of Molecular Sciences;2022-12-21

4. The EphB6 Receptor: Kinase-Dead but Very Much Alive;International Journal of Molecular Sciences;2021-07-30

5. EphA2 and EGFR: Friends in Life, Partners in Crime. Can EphA2 Be a Predictive Biomarker of Response to Anti-EGFR Agents?;Cancers;2021-02-09